Lv42
410 积分 2025-03-13 加入
Effects of once‐daily teneligliptin on 24‐h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4‐week, randomized, double‐blind, placebo‐controlled trial
9天前
已完结
Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes
9天前
已完结
DPP-4 inhibitors: pharmacological differences and their clinical implications
9天前
已完结
A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site
9天前
已完结
Abstract PO3-05-10: Efficacy and safety of eribulin plus gemcitabine in second-line or beyond for patients with HER2-negative metastatic breast cancer (MBC): A multi-center, open-label, single-arm, phase II study
2个月前
已完结
Abstract PO3-05-10: Efficacy and safety of eribulin plus gemcitabine in second-line or beyond for patients with HER2-negative metastatic breast cancer (MBC): A multi-center, open-label, single-arm, phase II study
2个月前
已完结
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE) in Locally Advanced or Metastatic Breast Cancer: Prospective Cohort Study
3个月前
已完结
Advancing treatment efficacy: combined therapy of eribulin, anlotinib, and camrelizumab in advanced or metastatic retroperitoneal liposarcoma
4个月前
已完结
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
4个月前
已完结
Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single‐arm phase II trial
4个月前
已完结
皖公网安备34019202002308
